|4May 15, 6:14 PM ET

Alland Leila 4

4 · PMV Pharmaceuticals, Inc. · Filed May 15, 2023

Insider Transaction Report

Form 4
Period: 2023-05-12
Alland Leila
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-05-12+100,000100,000 total
    Exercise: $5.70Exp: 2033-05-12Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION